
Anthias Biopharma Private Limited
About Anthias Biopharma Private Limited
Data last updated:
Anthias Biopharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC317397. Its GSTIN is 27AARCA5998B1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shreyasi Agrawal and Shalini Vinod Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 405 P S Centre Daftary Road Malad E Opp. Railway Station, Mumbai, Maharashtra, India – 400064.
As per the financials filed for FY 2022, the company reported a revenue of ₹43.83 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹25.32 Lakh (net margin -57.8%) and EBITDA of -₹29.42 Lakh (EBITDA margin -67.1%).
Company details
Contact details
Anthias Biopharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 405 P S Centre Daftary Road Malad E Opp. Railway Station, Mumbai, Maharashtra, India – 400064
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Anthias Biopharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Anthias Biopharma Private Limited
FY 2025 filings availableAnthias Biopharma Private Limited reported revenue of ₹43.83 Lakh (up 713% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 713% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹43.83 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹29.42 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹25.32 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -67.1% | |||
| Net Profit Margin | -57.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Anthias Biopharma Private Limited, buy the company report.
Board of directors of Anthias Biopharma Private Limited
Anthias Biopharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreyasi Agrawal Also directs: Aaja Residency Private Limited | Director | 26 Nov 2018 | 7 Years 11 Months | Current |
| Shalini Vinod Agarwal Also directs: Aaja Residency Private Limited | Director | 26 Nov 2018 | 7 Years 11 Months | Current |
Auditor
Anthias Biopharma Private Limited is audited by N D SAVLA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N D SAVLA & ASSOCIATES | FY 2022 | 141055W |
Shareholding
The shareholding of Anthias Biopharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Anthias Biopharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anthias Biopharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anthias Biopharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anthias Biopharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AARCA5998B1Z6 | Maharashtra | Active | 26 Feb 2020 |
To see the full GST registrations and return filing status of Anthias Biopharma Private Limited, buy the company report.
Recent activity
Anthias Biopharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Shalini Vinod Agarwal was appointed as Director on 26 Nov 2018.
Frequently asked questions
Anthias Biopharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 2018 (8+ years old) and is registered under CIN U74999MH2018PTC317397.
Anthias Biopharma has 2 current directors:
- Shreyasi Agrawal - Director
- Shalini Vinod Agarwal - Director
The latest financial statements of Anthias Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Anthias Biopharma is 27AARCA5998B1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Anthias Biopharma is U74999MH2018PTC317397. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anthias Biopharma was incorporated on 26 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Shalini Vinod Agarwal was appointed as Director on 26 Nov 2018. Shreyasi Agrawal was appointed as Director on 26 Nov 2018.
The registered office of Anthias Biopharma is at Flat No. 405 P S Centre Daftary Road Malad E Opp. Railway Station, Mumbai, Maharashtra, India – 400064.
Anthias Biopharma operates in the pharma industry, in the drug formulation and development segment.
Anthias Biopharma can be reached at its registered office: Flat No. 405 P S Centre Daftary Road Malad E Opp. Railway Station, Mumbai, Maharashtra, India – 400064.

